Alzamend Neuro, Inc. (ALZN) income statement
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$0.78−0.24 (-23.94%)
Close on Nov 20, 2026Market cap $3.74MP/E –Yield –
Alzamend Neuro, Inc. income statement
Ratios
Latest available, balances at Jul 31, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -373.2%
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.65
- Dividend yield
- –
See a number that looks wrong?